@article{ref1,
title="Cardiotoxicity associated with intentional ziprasidone and bupropion overdose",
journal="Journal of toxicology - clinical toxicology",
year="2003",
author="Biswas, Abhik K. and Zabrocki, Luke A. and Mayes, Kendra L. and Morris-Kukoski, Cynthia L.",
volume="41",
number="1",
pages="79-82",
abstract="BACKGROUND: Ziprasidone (Geodon) and bupropion (Wellbutrin) are medications prescribed for mood and behavior disorders. They have apparently safe cardiac safety profiles in both therapeutic and supra-therapeutic doses. CASE REPORT: A 17-year-old male developed a widened QRS and a prolonged QTc interval following an overdose of ziprasidone and bupropion. He required hospital admission for aggressive cardiac monitoring and antidysrhythmic therapy, stabilizing to baseline by 80 hours post-ingestion. CONCLUSIONS: We present a case that underscores the potential cardiotoxicities of these medications. Ziprasidone and bupropion ingestion can be associated with cardiotoxicities that may require several days of aggressive cardiac monitoring and treatment.<p /><p>Language: en</p>",
language="en",
issn="0731-3810",
doi="",
url="http://dx.doi.org/"
}